ITPC-MENA

Nouveautés sur le Web

• 21 mai – Majority of Italian HIV specialists would prescribe PrEP
• 20 mai – Case workers can re-engage a high proportion of HIV-positive people lost to long-term care
• 18 mai – Higher rates of HIV in US black gay men may be due to smaller choice of partners and more age mixing
• 16 mai – Dramatic improvements in HIV testing are possible – local leadership and multiple initiatives required
• 16 mai – Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
• 16 mai – Engagement with health care leads to more prompt HIV diagnosis and higher rates of virological suppression among gay men
• 15 mai – Hepatitis E virus infection can cause rapid liver cirrhosis in people with HIV who have low CD4 cell counts
• 14 mai – More drugs, more alcohol often means more risky sex for HIV-negative gay men
• 13 mai – People more likely to keep HIV clinic appointments if they believe their care providers know them as a person
• 11 mai – New HCV combinations could have a big role in prevention, but only if treatment rates increase
• 10 mai – Up to a third of HIV infections in European gay men may have come from another country
• 9 mai – Movement for global access to hepatitis C treatment building momentum
• 9 mai – Herpes viruses associated with shedding of HIV in the semen of gay men taking suppressive antiretroviral therapy
• 7 mai – Report highlights major failings in UK response to hepatitis C
• 7 mai – High prevalence of oral HPV infection in Dutch gay men
• 2 mai – Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination
• 1er mai – Blackmail, violence and stigma restrict access to sexual health services for gay men, Global Health and Rights Study reports
• 30 avril – Compassionate access to new hepatitis C drugs an "emergency" for European patients
• 30 avril – Les rapports de la consultation les défis de la mise en oeuvre du traitement comme prévention (TasP) - 30/04/2013
• 30 avril – Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%
• 30 avril – Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C
• 30 avril – Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
• 29 avril – Hep C quad regimens quashed, but some components go forward
• 29 avril – Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care
• 29 avril – A majority of HIV-positive gay men in Dutch survey take their viral load into consideration if having unprotected sex
• 26 avril – Researchers stop the only current HIV vaccine efficacy trial
• 26 avril – AbbVie interferon-free combination cures over 90% of hepatitis C genotype 1
• 26 avril – Sofosbuvir + ribavirin cures most genotype 2 hepatitis C, but genotype 3 response is lower
• 25 avril – Consistent decline in partner numbers in US gay men in last decade, but no change in condom use
• 24 avril – Genetics make a large contribution to cardiovascular risk for people with HIV
• 23 avril – For African women in the UK, formula feeding has a high social and personal cost
• 23 avril – Some barriers to adherence for black African people in London are culturally specific
• 22 avril – London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained
• 22 avril – Training for GPs can increase HIV testing rate
• 18 avril – Elevated prevalence of HIV and viral hepatitis in men injecting anabolic steroids
• 18 avril – England: health and wellbeing boards not prioritising HIV
• 18 avril – Integrating HIV care into community health workers' role is a good model for southern Africa
• 17 avril – South African clinics already achieving zero new HIV infections in children
• 16 avril – Liver disease a major cause of illness and death across the EU: action needed to save lives
• 15 avril – Life expectancy for South African patients who start HIV therapy with CD4 cell counts above 200 is 'near normal'
• 15 avril – PrEP doesn't lead to increases in risky sex among gay men
• 12 avril – CMV replication associated with increased mortality risk in Thai patients starting HIV therapy
• 11 avril – Treating everyone diagnosed would not end HIV in US gay men, Los Angeles-based model finds
• 11 avril – Viral load in genital secretions differs between men and women undergoing HIV therapy
• 10 avril – No increase in sexual risk taking by gay men in England, 2001 to 2008
• 10 avril – Hepatitis C epidemic in US gay men is decades old
• 9 avril – One-in-four deaths in pregnancy due to HIV in worst-affected countries
• 8 avril – Marriage is a risk factor for HIV infection in Malawi
• 5 avril – Disagreements about agreements – many gay couples lack clarity on sex outside their relationship
• 5 avril – Concentrations of HIV protease inhibitors increase with age
• 4 avril – Review shows HIV self-testing to be acceptable, accurate and feasible, but finds little data on linkage to care for those testing HIV positive
• 4 avril – KS-associated IRIS common among people starting HIV therapy in Africa
• 3 avril – Les personnes séropositives répondant bien au traitement antirétroviral devraient être admissibles à une couverture d’assurance vie
• 3 avril – Tenofovir and 3TC prevent new hepatitis B infections in gay men living with HIV
• 2 avril – Drinking coffee halves the risk of liver cancer
• 2 avril – Very high incidence of high-grade pre-cancerous anal lesions among young HIV-positive Thai gay men
• 1er avril – Long-term suppression of viral load and sustained CD4 cell increase reduce risk of cervical HPV infection for HIV-positive women
• 29 mars – Recruitment through social networks is an efficient way to increase demand for HIV testing among high-risk groups
• 28 mars – Almost three-quarters of people starting HIV therapy in Tanzania have dyslipidemia after three years of treatment
• 28 mars – Point-of-care viral load testing potentially cost-effective in southern Africa